A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform
The reference methods used for sickle cell disease (SCD) screening usually include two analytical steps: a first tier for differentiating haemoglobin S (HbS) heterozygotes, HbS homozygotes and β-thalassemia from other samples, and a confirmatory second tier. Here, we evaluated a first-tier approach...
Saved in:
Main Authors: | Pierre Naubourg (Author), Marven El Osta (Author), David Rageot (Author), Olivier Grunewald (Author), Gilles Renom (Author), Patrick Ducoroy (Author), Jean-Marc Périni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell Disease
by: Marven El Osta, et al.
Published: (2019) -
MALDI-TOF MS in the clinical microbiology laboratory
by: Marcelo Jenne Mimica, et al.
Published: (2013) -
Evaluation of MALDI-TOF MS in the microbiology laboratory
by: Anderson Fernandes Santos, et al.
Published: (2013) -
Highly multiplexed quantifications of 299 somatic mutations in colorectal cancer patients by automated MALDI-TOF mass spectrometry
by: Chang Xu, et al.
Published: (2020) -
Reducing Postoperative Opioids in Pediatric Orthopaedics: An Updated Tiered Prescription Guideline with a "Tier 0"
by: Mikaela H. Sullivan, MD, et al.
Published: (2024)